跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,704 条关于
“Tang Capital Management”
全部
28,704
临床试验
17,895
药物
303
机构
318
资讯
10,188
9个月前
Tang Capital Management Invests $56.8 Million in Celcuity Following Positive Phase 3 Gedatolisib Results
去年
Context Therapeutics Acquires Rights to BioAtla's Nectin-4 x CD3 TCE, BA3362, for up to $133 Million
11个月前
FDA Director Criticizes Lupus Nephritis Drug Lupkynis, Questions Surrogate Endpoint Approvals
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
6个月前
Superstring Capital Management Invests $6.84 Million in CNS Drug Developer Axsome Therapeutics
去年
Tang Capital's Concentra Biosciences Acquires Elevation Oncology for $0.36 Per Share in Latest Biotech Liquidation
6个月前
ACT Capital Management Invests $8 Million in TG Therapeutics Despite 30% Stock Decline
去年
Baekhogainsam-Tang and Low-Dose Pilocarpine Combination Shows Promise for Xerostomia
3个月前
China Approves First Class 3.1 Classical Formula Drug Zhenwu Tang Granules, Marking TCM Modernization Milestone
去年
Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment
第 1 页,共 1019 页
上一页
下一页